GS1191-0445 injection
GS1191-0445-GTHA-CN02
Phase 3 small_molecule active
Quick answer
GS1191-0445 injection for Hemophilia A is a Phase 3 program (small_molecule) at Gritgen Therapeutics Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Gritgen Therapeutics Co.,
- Indication
- Hemophilia A
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active